Hungarian Brain Research Program(KTIA_NAP_13-2-2015-0001)
(2017 − 1.2.1-NKP-2017-00002)
(National Brain Programme 3.0(NAP2022-I-4/2022))
(TKP2021-EGA-25)
(K 143391)
(2024–2.1.1-EKOP-2024–00004)
Szakterületek:
Gyógyszerészet, farmakogenomika, gyógyszerkutatás és tervezés, gyógyszeres kezelés
Major depressive disorder (MDD) is a complex psychiatric condition significantly impacted
by environmental stress and inflammation. Previous research suggests that stress-induced
alterations in the blood-brain barrier (BBB) may allow pro-inflammatory cytokines
like interleukin-6 (IL-6) to enter the brain, contributing to depression. Tumor necrosis
factor-alpha (TNF-α) is another prominent cytokine implicated in depression, but its
role in the context of BBB integrity and stress-mediated depression remains unclear.This
study aimed to investigate whether TNF-α plays a similar role as IL-6 in the development
of depression through interactions with environmental stress and BBB integrity. Specifically,
we examined the interaction between environmental stress, genetic variants of CLDN5
(the gene of the Claudin-5, a protein critical for BBB integrity), and TNF (the gene
encoding the TNF-α protein) genetic variants on depressive symptoms.We utilized data
from the UK Biobank, comprising genetic, health, and lifestyle information from approximately
500,000 participants aged 40 to 69. Depressive symptoms were assessed using the Patient
Health Questionnaire-9 (PHQ-9) and a composite Current Depressive Symptoms (CDS) score
based on self-reported questionnaire items. Environmental stress was quantified through
participants' reports of significant life events in the past two years. Genetic analysis
focused on 15 single nucleotide polymorphisms (SNPs) within the TNF gene (after linkage
disequilibrium pruning) and a functional polymorphism in CLDN5 (rs885985). Linear
regression models were used to assess main effects, gene-gene interactions, gene-environment
interactions, and three-way interactions on depressive symptoms, adjusting for covariates
and applying Bonferroni correction for multiple testing.No significant associations
were found between TNF genetic variants and depressive symptoms after correcting for
multiple testing. While some TNF SNPs showed nominal significance in interaction models
- most notably rs3093546, which showed nominal significance in both depressive phenotypes
- the findings were not robust enough to confirm a significant role. Unlike previous
findings with IL6, TNF did not exhibit significant interactions with environmental
stress and CLDN5 variants affecting depression risk.The study does not support a significant
role for TNF genetic variants interacting with environmental stress and BBB integrity
in influencing depression risk. These findings suggest that IL-6 and BBB integrity
may be more critical targets for understanding and treating stress-related depression,
highlighting the complexity of depression's pathophysiology.(Neuropsychopharmacol
Hung 2024; 26(4): 197-203)